Key facts
- Ultra Pouches’s last known valuation is $76.0M (Jan 2026).
- It has raised $12.4M; the latest was Early Stage VC ($11.0M) in Jan 2026.
- Notable investors include Left Lane Capital, Good Friends, Sugar Capital, Barrel Ventures, Dak Prescott — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Ultra Pouches
- ·The full record, as it builds
Funding rounds
No funding rounds for Ultra Pouches are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ultra Pouches
Manufacturer of nicotine-free oral pouches intended to support everyday mental focus and sustained energy. The company offers oral pouches made with carefully selected natural ingredients, enabling working adults and students to stay attentive and mentally steady during periods of concentration.
- Sector
- Consumer Products and Services (B2C)
- HQ
- New York, NY, United States
- Founded
- 2025
- Employees
- 6
- Website
- takeultra.com/
- Ownership
- Privately Held (backing)
Ultra Pouches doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ultra Pouches shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ultra Pouches in its N-PORT filings yet. We sweep new filings monthly.